Steward Partners Investment Advisory’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-500
Closed -$1.92K 4806
2026
Q1
$1.92K Hold
500
﹤0.01% 4068
2025
Q4
$1.85K Hold
500
﹤0.01% 3979
2025
Q3
$7.06K Sell
500
-660
-57% -$10.3K ﹤0.01% 3537
2025
Q2
$22.3K Hold
1,160
﹤0.01% 2870
2025
Q1
$12.8K Hold
1,160
﹤0.01% 2987
2024
Q4
$19.3K Hold
1,160
﹤0.01% 2817
2024
Q3
$11.8K Buy
1,160
+1,000
+625% +$29.7K ﹤0.01% 2884
2024
Q2
$9.24K Hold
160
﹤0.01% 2845
2024
Q1
$5.33K Buy
+160
New +$8.1K ﹤0.01% 3023

Other funds holding OM

Steward Partners Investment Advisory's OM Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Outset Medical (OM) in Q2 2026, closing a stake of 500 shares — an estimated $1.92K sold.

Steward Partners Investment Advisory first reported a position in OM in Q1 2024 and held it in 9 quarters. The position peaked at $22.3K in Q2 2025. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Steward Partners Investment Advisory reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 500 Outset Medical shares in Q2 2026, an estimated $1.92K.
  • Steward Partners Investment Advisory first reported a position in Outset Medical in Q1 2024 and held it in 9 quarters.
  • Steward Partners Investment Advisory's Outset Medical position peaked at $22.3K in Q2 2025.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.